BEAM FY 2022 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$61M+17.5% YoY

Gross Profit

-$251M-411.5% margin

Operating Income

-$338M-555.6% margin

Net Income

-$289M-474.5% margin

EPS (Diluted)

$-4.13

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

-$26M

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$608M

Stockholders' Equity

$733M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$52M	+17.5%
Gross Profit	-$251M	-$180M	-39.0%
Operating Income	-$338M	-$392M	+13.8%
Net Income	-$289M	-$371M	+22.0%